BPC-157, short for Body Protection Compound-157, is a derivative of body protection compound (BPC)
Despite these concerns, there is currently no evidence to suggest that BPC57 has caused tumors to grow more quickly in humans or animals, and most compounds that are carcinogenic will show a signature of cancer in animal studies 6m30s
the full protein and the synthetic fragment have distinct research applications
Red flags requiring urgent assessment include rapidly progressive neurological symptoms, new onset ataxia or gait disturbance, visual changes, severe weakness, or confusion
The Business Briefing newsletter delivers major stories, exclusive coverage and expert opinion
Peptide therapy addresses all three energy, cognition, and recovery through a single physician-supervised protocol